Pure Global

VH4524184 Proof-of-Concept in Treatment-Naïve Adults Living With HIV-1 - Trial NCT06214052

Access comprehensive clinical trial information for NCT06214052 through Pure Global AI's free database. This Phase 2 trial is sponsored by ViiV Healthcare and is currently Not yet recruiting. The study focuses on HIV Infections. Target enrollment is 28 participants.

This page provides complete trial specifications, intervention details, outcomes, and location information. Pure Global AI offers free access to ClinicalTrials.gov data, helping medical device and pharmaceutical companies navigate clinical research efficiently.

Free Database
Powered by Pure Global AI
840K+ Trials
NCT06214052
Phase 2
Not yet recruiting
drug
Trial Details
ClinicalTrials.gov • NCT06214052
View on ClinicalTrials.gov
Pure Global
DJ Fang

DJ Fang

MedTech Regulatory Expert

Need help with 30+ markets registration?

Pricing
VH4524184 Proof-of-Concept in Treatment-Naïve Adults Living With HIV-1
A Phase 2a, Randomized, Double-Blind (Sponsor Unblinded), Placebo-Controlled, Study to Investigate the Antiviral Effect, Safety, Tolerability and Pharmacokinetics of VH4524184 in HIV-1 Infected Treatment Naïve Adults

Study Focus

HIV Infections

VH4524184

Interventional

drug

Sponsor & Location

ViiV Healthcare

Bakersfield,Los Angeles,Los Angeles,Palm Springs,DeLand,Orlando,Tampa,Newark,Ciudad Autónoma de Buenos Aires,Almagro,Buenos Aires,Toronto,Montreal,Québec,Padova,Milano,Monza,San Pedro Garza García,Chi, Argentina,Canada,Italy,Mexico,Spain,United States of America

Timeline & Enrollment

Phase 2

Feb 14, 2024

Sep 16, 2024

28 participants

Primary Outcome

Maximum Change from Baseline in logarithm in 10 base (log10) Plasma HIV-1 Ribonucleic Acid (RNA) Through Day 10

Summary

The purpose of this study is to evaluate the safety, tolerability, ability of VH4524184 when
 given alone to reduce the amount of HIV (viral load) in people with HIV-1 infection who have
 never received antiretroviral therapy (treatment-naïve). Data from this study will be used to
 decide how VH4524184 can be best included in a full-treatment regimen for HIV-1 in the
 future.

ICD-10 Classifications

HIV disease resulting in other viral infections
HIV disease resulting in other bacterial infections
HIV disease resulting in multiple infections
Acute HIV infection syndrome
HIV disease resulting in other infectious and parasitic diseases

Data Source

ClinicalTrials.gov

NCT06214052

Non-Device Trial